CROI 2017 Program and Information

Program and Agenda

551 SAME SAME BUT DIFFERENT? RISK OF DAA THERAPY FAILURE IN REAL-LIFE HCV/HIV COINFECTION Christoph Boesecke 1 , Patrick Ingiliz 2 , Florian Berger 3 , Thomas Lutz 4 , Knud Schewe 5 , Julian Schulze zur Wiesch 6 , Axel Baumgarten 2 , Stefan Christensen 7 , Jürgen K. Rockstroh 1 , Stefan Mauss 3 1 Univ Hosp Bonn, Bonn, Germany, 2 Cntr for Infectiology, Berlin, Germany, 3 Cntr for HIV and Hepatogastroenterology, Duesseldorf, Germany, 4 Infektiologikum, Frankfurt, Germany, 5 dagnae e.V., Berlin, Germany, 6 Univ Med Cntr, Hamburg–Eppendorf, Hamburg, Germany, 7 CIM Infectious Diseases, Münster, Germany 552 DIRECT-ACTING ANTIVIRALS IMPROVE ACCESS TO CARE AND CURE FOR PATIENTSWITHHIV-HCV Lauren F. Collins , Austin Chan, Jiayin Zheng, Shein-Chung Chow, Julius M. Wilder, Andrew J. Muir, Susanna Naggie Duke Univ, Durham, NC, USA 553 DIRECT ACTING ANTIVIRAL UPTAKE DISPARITIES INHIV/HCV– COINFECTED POPULATIONS Sahar Saeed 1 , Erin C. Strumpf 1 , Sharon Walmsley 2 , Curtis Cooper 3 , Brian Conway 4 , Valerie-Martel Laferriere 5 , Neora Pick 6 , Alexander Wong 7 , Marina Klein 8 , for the Canadian Co-Infection Cohort Study 1 McGill Univ, Montreal , Canada, 2 Univ of Toronto, Toronto, Ontario, Canada, 3 Ottawa General Rsr Inst, Ottawa, Ontario, Canada, 4 Vancouver Infectious Diseases Cntr, Vancouver, Canada, 5 Cntr Hosp de l’Univ de Montréal, Montreal, Canada, 6 Oak Tree Clinic, Vancouver, Canada, 7 Regina Qu‘Appelle Hlth Region, Regina, Canada, 8 McGill Univ Hlth Cntr Rsr Inst, Montreal, Ontario, Canada 554 HCV TREATMENT IN PEOPLEWHO INJECT DRUGS COLOCATED WITHINNEEDLE AND SYRINGE PROGRAM Benjamin Eckhardt 1 , Kristen M. Marks 2 , Brian Edlin 3 1 New York Univ, New York, NY, USA, 2 Weill Cornell Med, New York, NY, USA, 3 Natl Development and Rsr Insts, New York, NY, USA 555 HIGH EFFICACY OF IFN-FREE ANTI-HCV REGIMENS FOR INDIVIDUALS ON OPIATE AGONIST THERAPY Juan Macías 1 , Luis E. Morano-Amado 2 , Francisca Cuenca-Lopez 3 , Miriam Serrano 4 , Karin Neukam 1 , Francisco Téllez 5 , Manuel Márquez 6 , Dolores Merino 7 , Juan A. Pineda 1 1 Hosp Univ de Valme, Sevilla, Spain, 2 Hosp Univ Alvaro Cunqueiro, Vigo, Spain, 3 Hosp Univ Reina Sofia, Cordoba, Spain, 4 Hosp Univ de Gran Canaria Dr Negrín, Las Palmas, Gran Canaria, 5 Hosp de La Línea, La Línea de la Concepción, Spain, 6 Hosp Virgen de la Victoria, Málaga, Spain, 7 Complejo Hospario Univ de Huelva, Huelva, Spain 556 SVR12 FOR PATIENTSWITH BEHAVIORAL HEALTH CONDITIONS TREATED FOR HEPATITIS C IN FQHCS Sophy S. Wong , Megan Crowley, Jan Diamond Alameda Hlth Consortium, San Leandro, CA, USA 557 REAL-WORLD OUTCOMES OF HCV TREATMENT INHOMELESS ANDMARGINALLY HOUSED ADULTS Joshua A. Barocas 1 , Marguerite Beiser 2 , Casey Leon 2 , Molly Ingemi 2 , Paul McCabe 3 , Lena Cardoso 2 , Benjamin Linas 4 , James O’Connell 2 1 Massachusetts General Hosp, Boston, MA, USA, 2 Boston Hlth Care for the Homeless, Boston, MA, USA, 3 Quinnipiac Univ, North Haven, CT, USA, 4 Boston Univ, Boston, MA, USA

Poster Sessions • Wednesday

CROI 2017 139